NC-IUPHAR
section
The NC‑IUPHAR Section leads the international standardization of pharmacological nomenclature and classification, providing authoritative frameworks for biological targets and drug interactions.
Through expert-driven guidelines and the development of the Guide to Pharmacology, it supports research, education, and innovation by ensuring clarity, consistency, and accessibility across the global pharmacology community within IUPHAR.
The NC‑IUPHAR Section leads the international standardization of pharmacological nomenclature and classification, providing authoritative frameworks for biological targets and drug interactions.
Through expert-driven guidelines and the development of the Guide to Pharmacology, it supports research, education, and innovation by ensuring clarity, consistency, and accessibility across the global pharmacology community within IUPHAR.
Aims of the NC-IUPHAR division
- Issuing guidelines for the nomenclature and classification of all the (human) biological targets, including all the targets of current and future prescription medicines;
- Facilitating the interface between the discovery of new sequences from the Human Genome Project and the designation of the derived entities as functional biological targets and potential drug targets;
- Designating polymorphisms and variants which are functionally important;
- Developing an authoritative and freely available, global online resource, the IUPHAR Database, which is now accessible via the Guide to PHARMACOLOGY portal, with a remit to:
- provide access to data on all known biological targets;
- enable students and scientists in academia and industry, working in areas related to pharmacology and drug/target research, to exploit the full potential of the considerable amount of information on drug action available in the published literature;
- provide an entry point into the pharmacological literature for basic and clinical scientists from other disciplines;
- provide an integrated educational resource with access to high quality training in the principles of basic and clinical pharmacology and techniques;
- foster innovative drug discovery.